NORTHERN VIRGINIA – Feb. 28, 2023 – Greenberg Traurig, LLP represented Embody Inc., a privately held medical device company focused on soft tissue healing, in its recent sale to Zimmer Biomet Holdings (NYSE and SIX: ZBH).
The acquisition of Norfolk, Virginia-based Embody was structured as a tax-free reorganization and included an upfront payment valued at approximately $155 million with payments of up to an additional $120 million subject to achieving future regulatory and commercial milestones.
The acquisition includes Embody's complete portfolio of collagen-based biointegrative solutions to support healing in the most challenging orthopedic soft tissue injuries – including the TAPESTRY® biointegrative implant for tendon healing and TAPESTRY® RC, one of the first arthroscopic implant systems for rotator cuff repair.
Scott Meza and Jason T. Simon, corporate shareholders based in Greenberg Traurig’s Northern Virginia office, represented Embody in the sale to Zimmer Biomet.